Minireview: Therapeutic potential of myricetin in diabetes mellitus
Tóm tắt
Từ khóa
Tài liệu tham khảo
Whiting, 2011, IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030, Diabetes Res. Clin. Pract., 94, 311, 10.1016/j.diabres.2011.10.029
Jeffcoate, 2004, Diabetes control and complications: the role of glycated haemoglobin 25 years on, Diabet. Med., 21, 657, 10.1046/j.1464-5491.2003.01065.x
Harnly, 2006, Flavonoid content of US fruits, vegetables, and nuts, J. Agric. Food Chem., 54, 9966, 10.1021/jf061478a
Lin, 2006, Flavonoid intake and colorectal cancer risk in men and women, Am. J. Epidemiol., 164, 644, 10.1093/aje/kwj296
Kim, 2004, Comprehensive study on vitamin C equivalent antioxidant capacity (VCEAC) of various polyphenolics in scavenging a free radical and its structural relationship, Crit. Rev. Food Sci. Nutr., 44, 253, 10.1080/10408690490464960
Chen, 1996, Antioxidant activity of natural flavonoids is governed by number and location of their aromatic hydroxyl groups, Chem. Phys. Lipids, 79, 157, 10.1016/0009-3084(96)02523-6
Mira, 2002, Interactions of flavonoids with iron and copper ions; a mechanism for their antioxidant activity, Free Radic. Res., 36, 1199, 10.1080/1071576021000016463
Kang, 2011, Myricetin is a potent chemopreventive phytochemical in skin carcinogenesis, Ann. N. Y. Acad. Sci., 1229, 124, 10.1111/j.1749-6632.2011.06122.x
Shimmyo, 2008, Three distinct neuroprotective functions of myricetin against glutamate-induced neuronal cell death; involvement of direct inhibition of caspase-3, J. Neurosci. Res., 86, 1836, 10.1002/jnr.21629
Knekt, 2002, Flavonoid intake and risk of chronic diseases, Am. J. Clin. Nutr., 76, 560, 10.1093/ajcn/76.3.560
Cushnie, 2005, Antimicrobial activity of flavonoids, Int. J. Antimicrob. Agents, 26, 343, 10.1016/j.ijantimicag.2005.09.002
Gray, 1997, Nature's own pharmacy; the diabetes perspective, Proc. Nutr. Soc., 56, 507, 10.1079/PNS19970051
Barbosa-Filho, 2005, Plants and their active constituents from South, Central, and North America with hypoglycemic activity, Rev. Bras. Farmacogn., 15, 392, 10.1590/S0102-695X2005000400021
Mendez, 1995, Phytochemical investigations of Licania genus. Flavonoids and triterpenoids from Licania pittieri, Pharm. Acta Helv., 70, 223, 10.1016/0031-6865(95)00027-7
M.J. Ahrens, D.L. Thompson, Composition and method for treating diabetes and metabolic disorders. United States Patent Application Publication 2011. US 2011/0118345 A1.
M.A. Mazed, S. Mazed, Nutritional supplement for the prevention of cardiovascular disease, Alzheimer's disease, diabetes, and regulation and reduction of blood sugar and insulin resistance. United States Patent Application Publication 2009. US 2009/0252796 A1.
Song, 2005, Associations of dietary flavonoids with risk of type 2 diabetes, and markers of insulin resistance and systemic inflammation in women: a prospective study and cross-sectional analysis, J. Am. Coll. Nutr., 24, 376, 10.1080/07315724.2005.10719488
Liu, 2005, Myricetin as the active principle of Abelmoschus moschatus to lower plasma glucose in streptozotocin-induced diabetic rats, Planta Med., 71, 617, 10.1055/s-2005-871266
Ong, 2000, Effects of myricetin on glycemia and glycogen metabolism in diabetic rats, Life Sci., 67, 1695, 10.1016/S0024-3205(00)00758-X
Kwon, 2007, Inhibition of the intestinal glucose transporter GLUT2 by flavonoids, FASEB J., 21, 366, 10.1096/fj.06-6620com
Liu, 2007, Myricetin, a naturally occurring flavonol, ameliorates insulin resistance induced by a high-fructose diet in rats, Life Sci., 81, 1479, 10.1016/j.lfs.2007.08.045
Liu, 2007, Improvement of insulin sensitivity in obese Zucker rats by myricetin extracted from Abelmoschus moschatus, Planta Med., 73, 1054, 10.1055/s-2007-981577
Tzeng, 2011, Myricetin ameliorates defective post-receptor insulin signaling via beta-endorphin signaling in the skeletal muscles of fructose-fed rats, Evid. Based Complem. Alternat. Med., 2011, 150, 10.1093/ecam/neq017
Ding, 2012, Myricetin attenuates hyperinsulinemia-induced insulin resistance in skeletal muscle cells, Eur. Food Res. Technol., 234, 873, 10.1007/s00217-012-1701-3
Ong, 1996, Insulinomimetic effects of myricetin on lipogenesis and glucose transport in rat adipocytes but not glucose transport translocation, Biochem. Pharmacol., 51, 423, 10.1016/0006-2952(95)02195-7
Watanabe, 1991, Induction of in vitro differentiation of mouse erythroleukemia cells by genistein, an inhibitor of tyrosine protein kinases, Cancer Res., 51, 764
Strobel, 2005, Myricetin, quercetin and catechin-gallate inhibit glucose uptake in isolated rat adipocytes, Biochem. J., 386, 471, 10.1042/BJ20040703
Kang, 2005, Inhibition of interleukin-12 production in mouse macrophages via decreased nuclear factor-kappaB DNA binding activity by myricetin, a naturally occurring flavonoid, Arch. Pharm. Res., 28, 274, 10.1007/BF02977791
Lee, 2010, Myricetin inhibits IL-1beta-induced inflammatory mediators in SW982 human synovial sarcoma cells, Int. Immunopharmacol., 10, 812, 10.1016/j.intimp.2010.04.010
Blonska, 2003, Effect of flavone derivatives on interleukin-1beta (IL-1beta) mRNA expression and IL-1beta protein synthesis in stimulated RAW 264.7 macrophages, Scand. J. Immunol., 57, 162, 10.1046/j.1365-3083.2003.01213.x
Kim, 2009, MKK4 is a novel target for the inhibition of tumor necrosis factor-alpha-induced vascular endothelial growth factor expression by myricetin, Biochem. Pharmacol., 77, 412, 10.1016/j.bcp.2008.10.027
Tsai, 1999, Suppression of TNF-α-mediated NF-κB activity by myricetin and other flavonoids through down-regulating the activity of IKK in ECV304 cells, J. Cell. Biochem., 74, 606, 10.1002/(SICI)1097-4644(19990915)74:4<606::AID-JCB10>3.0.CO;2-W
Cao, 2002, Antiangiogenic mechanisms of diet-derived polyphenols, J. Nutr. Biochem., 13, 380, 10.1016/S0955-2863(02)00204-8
Kuo, 2005, Myricetin inhibits the induction of anti-Fas IgM-, tumor necrosis factor-alpha- and interleukin-1beta-mediated apoptosis by Fas pathway inhibition in human osteoblastic cell line MG-63, Life Sci., 77, 2964, 10.1016/j.lfs.2005.05.026
de Prati, 2005, STAT1 as a new molecular target of anti-inflammatory treatment, Curr. Med. Chem., 12, 1819, 10.2174/0929867054546645
Cottet, 2001, SOCS-1 protein prevents Janus Kinase/STAT-dependent inhibition of beta cell insulin gene transcription and secretion in response to interferon-gamma, J. Biol. Chem., 276, 25862, 10.1074/jbc.M103235200
Suk, 2001, IFN-gamma/TNF-alpha synergism as the final effector in autoimmune diabetes: a key role for STAT1/IFN regulatory factor-1 pathway in pancreatic beta cell death, J. Immunol., 166, 4481, 10.4049/jimmunol.166.7.4481
Banes, 2004, Angiotensin II blockade prevents hyperglycemia-induced activation of JAK and STAT proteins in diabetic rat kidney glomeruli, Am. J. Physiol. Renal Physiol., 286, F653, 10.1152/ajprenal.00163.2003
Abidov, 2006, Effect of Blueberin on fasting glucose, C-reactive protein and plasma aminotransferases, in female volunteers with diabetes type 2; double-blind, placebo controlled clinical study, Georgian Med. News, 66
Ding, 2012, Myricetin protects against cytokine-induced cell death in RIN-m5f beta cells, J. Med. Food, 15, 733, 10.1089/jmf.2011.2033
Cheng, 2011, Impaired redox signaling and antioxidant gene expression in endothelial cells in diabetes: a role for mitochondria and the nuclear factor-E2-related factor 2-Kelch-like ECH-associated protein 1 defense pathway, Antioxid. Redox Signal., 14, 469, 10.1089/ars.2010.3283
Gordon, 1998, Antioxidant activity of quercetin and myricetin in liposomes, Chem. Phys. Lipids, 97, 79, 10.1016/S0009-3084(98)00098-X
Panickar, 2009, Myricetin and quercetin attenuate ischemic injury in glial cultures by different mechanisms
Aherne, 1999, Protection by the flavonoids myricetin, quercetin, and rutin against hydrogen peroxide-induced DNA damage in Caco-2 and Hep G2 cells, Nutr. Cancer, 34, 160, 10.1207/S15327914NC3402_6
Wang, 2007, Effect of flavonols on caspase-3, Bcl-2 and Bax expression in cardiomyocytes apoptosis, Chin. Pharm. J., 42, 49
Lee, 2008, Myricetin, a naturally occurring flavonoid, prevents 2-deoxy-d-ribose induced dysfunction and oxidative damage in osteoblastic MC3T3-E1 cells, Eur. J. Pharmacol., 591, 1, 10.1016/j.ejphar.2008.06.004
Zhang, 2011, Myricetin attenuated MPP(+)-induced cytotoxicity by anti-oxidation and inhibition of MKK4 and JNK activation in MES23.5 cells, Neuropharmacology, 61, 329, 10.1016/j.neuropharm.2011.04.021
Pandey, 2009, Myricetin may provide protection against oxidative stress in type 2 diabetic erythrocytes, Z. Naturforsch. C, 64, 626, 10.1515/znc-2009-9-1004
Rostoka, 2010, Effects of kaempferol and myricetin on inducible nitric oxide synthase expression and nitric oxide production in rats, Basic Clin. Pharmacol. Toxicol., 106, 461, 10.1111/j.1742-7843.2009.00526.x
Kaneko, 2005, Aldose reductase and AGE-RAGE pathways: key players in myocardial ischemic injury, Ann. N. Y. Acad. Sci., 1043, 702, 10.1196/annals.1333.081
Williamson, 1993, Hyperglycemic pseudohypoxia and diabetic complications, Diabetes, 42, 801, 10.2337/diab.42.6.801
Lal, 1997, Fructose-3-phosphate production and polyol pathway metabolism in diabetic rat hearts, Metabolism, 46, 1333, 10.1016/S0026-0495(97)90240-7
Kawanishi, 2003, Aldose reductase inhibitors from the nature, Curr. Med. Chem., 10, 1353, 10.2174/0929867033457304
Haraguchi, 1998, An inhibitor of aldose reductase and sorbitol accumulation from Anthocepharus chinensis, Planta Med., 64, 68, 10.1055/s-2006-957369
Lim, 2006, Rat lens aldose reductase inhibitory constituents of Nelumbo nucifera stamens, Phytother. Res., 20, 825, 10.1002/ptr.1847
Peyroux, 2006, Advanced glycation endproducts (AGEs); pharmacological inhibition in diabetes, Pathol. Biol. (Paris), 54, 405, 10.1016/j.patbio.2006.07.006
Matsuda, 2003, Structural requirements of flavonoids for inhibition of protein glycation and radical scavenging activities, Bioorg. Med. Chem., 11, 5317, 10.1016/j.bmc.2003.09.045
Ghaffari, 2007, Influence of flavonols as in vitro on low density lipoprotein glycation, Iran. Biomed. J., 11, 185
Urios, 2007, Flavonoids inhibit the formation of the cross-linking AGE pentosidine in collagen incubated with glucose, according to their structure, Eur. J. Nutr., 46, 139, 10.1007/s00394-007-0644-0
Dunn, 1990, Hyperlipidemia in diabetes mellitus, Diabetes Metab. Rev., 6, 47, 10.1002/dmr.5610060103
Liang, 2009, Hypolipidemic effect of myricetin, Chin. J. Lab. Diagn., 13, 1670
Godse, 2010, Effect of myricetin on blood pressure and metabolic alterations in fructose hypertensive rats, Pharm. Biol., 48, 494, 10.3109/13880200903188526
Borde, 2011, Effect of myricetin on deoxycorticosterone acetate (DOCA)-salt-hypertensive rats, Nat. Prod. Res., 25, 1549, 10.1080/14786410903335190
Tarling, 2008, The search for novel human pancreatic alpha-amylase inhibitors; high-throughput screening of terrestrial and marine natural product extracts, Chembiochem, 9, 433, 10.1002/cbic.200700470
Zraika, 2010, Toxic oligomers and islet beta cell death; guilty by association or convicted by circumstantial evidence, Diabetologia, 53, 1046, 10.1007/s00125-010-1671-6
Taniguchi, 2005, Inhibition of heparin-induced tau filament formation by phenothiazines, polyphenols, and porphyrins, J. Biol. Chem., 280, 7614, 10.1074/jbc.M408714200
Lyketsos, 2010, Depression and diabetes; more on what the relationship might be, Am. J. Psychiatry, 167, 496, 10.1176/appi.ajp.2010.10020243